- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01471756
Improving Complete Endoscopic Mucosal Resection (EMR) of Colorectal Neoplasia
September 5, 2014 updated by: Timothy Woodward, Mayo Clinic
Improving Complete Endoscopic Mucosal Resection (EMR) of Colorectal Neoplasia: A Randomized Prospective Comparison of Snares and Injectate in the Resection of Large Sessile Colonic Polyps
The investigators seek to compare two techniques of removing pre-cancerous lesions from the colon.
The investigators also will compare two solutions used during the procedure to determine if either solution allows for an improved removal of the tumors.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The primary aim of the study is to compare the efficacy, efficiency and safety of two types of snares used in Endoscopic Mucosal Resection (EMR), a combined needle and snare unit (ISnare, US Endoscopy) versus an oval braided snare with spiral wire (Snaremaster, Olympus).
The secondary aim is to explore whether EMR efficacy and efficiency is depended upon the injection solution used, saline versus Gonak (a solution containing HPMC, saline, and epinephrine) for EMR.
Study Type
Interventional
Enrollment (Actual)
66
Phase
- Phase 4
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Florida
-
Jacksonville, Florida, United States, 32224
- Mayo Clinic
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Sessile colorectal polyp
- laterally spreading lesions as defined by Paris Classification type II and > 1 cm or greater
Exclusion Criteria:
- Those with ulcerated depressed lesions (Paris type III) or biopsy proven invasive carcinoma
- Inflammatory bowel disease patients
- Coagulopathy ( INR> 1.5) that cannot be corrected
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Factorial Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: iSnare with Gonak solution
|
Standard of Care Procedure as described in ARM
|
|
Experimental: Snaremaster braided snare with Gonak solution
|
Standard of Care Procedure as described in ARM
|
|
Experimental: iSnare with saline solution
|
Standard of Care Procedure as described in ARM
|
|
Experimental: Snaremaster braided snare with saline solution
|
Standard of Care Procedure as described in ARM
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Efficacy of Two Devices used in EMR
Time Frame: 1 year
|
To explore the efficacy of two devices used in EMR (iSnare® system versus Snaremaster) as measured by the "Sydney Resection Quotient" (SRQ).
SRQ is defined as "lesion size in mm divided by the number of pieces to resect" .
|
1 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Compare the Use of Two Injectates
Time Frame: 1 year
|
To compare the use of two injectates (saline versus HPMC mixture) with respect to efficacy as measured by the aforementioned SRQ.
|
1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Timothy A Woodward, M.D., Mayo Clinic
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2011
Primary Completion (Actual)
July 1, 2013
Study Completion (Actual)
May 1, 2014
Study Registration Dates
First Submitted
September 29, 2011
First Submitted That Met QC Criteria
November 15, 2011
First Posted (Estimate)
November 16, 2011
Study Record Updates
Last Update Posted (Estimate)
September 8, 2014
Last Update Submitted That Met QC Criteria
September 5, 2014
Last Verified
September 1, 2014
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 10-008104
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Neoplasms
-
Sixth Affiliated Hospital, Sun Yat-sen UniversityRecruitingRectal Neoplasms | Colon Neoplasms | Metagenome | MicrobiotaChina
-
European Association for Endoscopic SurgeryWithdrawn
-
Moscow Clinical Scientific CenterRecruitingCecal Neoplasms | Colonic Neoplasms MalignantRussian Federation
-
H. Lee Moffitt Cancer Center and Research InstituteNot yet recruitingPeritoneal CarcinomatosisUnited States
-
Second Affiliated Hospital, School of Medicine,...RecruitingColonic NeoplasmsChina
-
Nanjing Medical UniversityNot yet recruitingMalignant Meningioma
-
Joshua PalmerRayzeBio, Inc.RecruitingRecurrent MeningiomaUnited States
-
Chang Gung Memorial HospitalNational Science and Technology CouncilRecruiting
-
Intergroupe Francophone de Cancerologie ThoraciqueRegeneron PharmaceuticalsNot yet recruiting
-
Royal North Shore HospitalNorthern Sydney and Central Coast Area Health ServiceRecruiting
Clinical Trials on Standard of Care Procedure as described in ARM
-
Mazandaran University of Medical SciencesCompletedCardiovascular Diseases | Depression, Anxiety Disorders | Follow-up StudyIran, Islamic Republic of
-
Sorlandet Hospital HFRecruitingIschemic Stroke | Atrial Fibrillation (AF) | Secondary Prevention | Arrhythmia Atrial | Atrial Fibrillation (Prevention of Stroke)Norway
-
Medical University of GrazRecruitingEffect of Skin to Skin Care in Preterm Neonates | Skin to Skin CareAustria
-
Can Tho University of Medicine and PharmacyRecruitingUncontrolled Asthma | Telemedicine-Based EducationVietnam
-
Karolinska InstitutetGöteborg University; Academic Primary Health Care Centre, SLSO, Region StockholmNot yet recruitingAdjustment Disorder With Work Inhibition | Exhaustion Disorder | Clinical Burnout
-
University of ManchesterUniversity College, London; Manchester University NHS Foundation Trust; patientMpower... and other collaboratorsCompletedLung Transplant; ComplicationsUnited Kingdom
-
Medical University of SilesiaRecruitingAtrioventricular Block | Arrythmia | Atrial Fibrillation (AF) | Remote Monitoring | TAVI(Transcatheter Aortic Valve Implantation)Poland, Italy
-
Peking Union Medical CollegeNot yet recruiting
-
University Hospital, BrestNot yet recruitingEndovascular Treatments | Endovascular Surgery | Peripheral ArterialFrance
-
Indiana UniversityActive, not recruitingNASH - Nonalcoholic Steatohepatitis | Cirrhosis, LiverUnited States